TSC has land resources and abundant experience in agricultural farming and processing. We have core technologies and niches in sugar industry, pig farming and Phalaenopsis, and have expanded our business territory to the United States, Canada and Vietnam. We have also expanded our businesses to commodity sales, leisure and accommodation, and other livelihood industries. We have gradually transformed from the traditional agriculture of pure sugar production and marketing into an integrated business of seven business divisions, including Sugar Business Division, Biotechnology Business Division, Agriculture Business Division, Petroleum Business Division, Livestock Business Division, Leisure Business Division and Marketing Business Division. Product sales and services are mainly in Taiwan, while overseas markets include the United States, Canada, mainland China, Hong Kong, Vietnam, Japan, Australia, and Europe.

　　By making use of TSC’s advantages of existing land and the core technology of pig farming, TSC actively converts pig manure and urine into biogas power generation for reuse, installs solar power generation devices on the roofs of our operation bases, unfavorable agricultural land, and detention ponds.In addition, TSC has also obtained the first Renewable Energy Certificate (REC) for biomass energy, we further conducted research on soil carbon sequestration and fixation of flue gas carbon dioxide, keeping abreast of global trends in circular economy, renewable energy, and net-zero emissions, taking a step forward toward sustainable management.

　　According to the transformation strategy planning, under the analysis of the investment evaluation team, we seek partners to establish cooperative relationships with the Company’s advantages of land, funds, technologies and other resources and accumulate the experience of professional evaluation and investment management to foster more solid and professional capabilities.

　　As of 2023, the major fields of business TSC has invested include Biotechnology and pharmaceuticals, health care products, livestock feed, high-speed rail, power generation, overseas sugar production. The total investment in 17 domestic and foreign private-owned enterprises amounted to approximately NTD 5.78 billion as of the end of 2023. In the domestic market, we have invested 15 companies, including Pfizer Biotech and others, with an investment of approximately NTD 5.254 billion, accounting for 90.9%. Investment is made in 2 foreign companies, such as Vietnam-Taiwan Sugar Co., Ltd., with an investment of approximately NTD 526 million, accounting for 9.1%. In 2022, we completed the investment and purchased stocks of TEC BioWorks Co., Ltd.